1 hr 5 min

#41: Christoph Lengauer - The 7 Key Success Factors of Building Great Life Science Companies‪.‬ Beginner's Mind

    • Entrepreneurship

This episode will discuss what it takes to build companies that develop novel therapies, vaccines, and diagnostics in the pharma industry.
Since the pandemic, everybody got familiar with the key elements of pharma product development.
But let’s take a closer look into the value chain of the industry.
What does it really take to pick up a technology and bring it to patients?
Questions we will discuss:
Some questions we will focus on:
What strategic approaches do exist for life science companies?How important is the team in developing a company to an IPO?Where can scientists find help when they want to start a company?About Christoph Lengauer (from Third Rock Ventures)
“The most powerful thing about being a part of this industry is having the opportunity to improve the lives of patients and their families.”Christoph loves the ideation of new company concepts and focuses on the formation, development, and strategy of our portfolio companies. He is an accomplished scientist and drug hunter with the ability to translate that knowledge, insight, and expertise into compelling business strategies. Christoph has contributed to the discovery and development of eight FDA-approved medicines.
Christoph is dedicated to making a dramatic difference in patients’ lives. He is enthusiastic about Third Rock’s approach to discover, launch and build great companies by focusing on bold ideas that meet at the intersection of science, strategy, business, and medicine. He is especially excited by initiatives at the firm focusing on the early detection of diseases in order to not only treat but cure patients.
By leveraging his experiences and networks from academia, pharma, and biotech, he hopes to continue building great teams that help young companies succeed with this important mission.
Over his career, Christoph has received numerous awards, including the Novartis Oncology’s President’s Award for Top Innovator, and has been elected to membership in the Johns Hopkins Society of Scholars.
About Third Rock Ventures
We discover, launch, and build great companies based on bold ideas that meet at the intersection of science, strategy, business, and medicine – where transformational science meets operational reality – providing the best opportunity to make a dramatic difference in patients’ lives.
A FORMULA FOR INNOVATION
We only invest in the best of those ideas. We are actively involved in the early stages of our companies’ development, typically serving as members of the founding management teams, to build a strong foundation, put in place the right people and culture, and set the companies on a path to scientific and operational excellence. We believe in the companies we launch and make big initial investments, often complemented by strategic alliances, to enable our companies to advance life-changing therapies, devices, and diagnostics. By creating value for patients, we create value for our investors.
Link to the Video of the Recording:
YouTube

Speaker:
Christoph Lengauer
Christian Soschner
Organizations:
CS Life Science Invest
Third Rock Ventures
Support the show (https://lsg2g.substack.com/subscribe?)

This episode will discuss what it takes to build companies that develop novel therapies, vaccines, and diagnostics in the pharma industry.
Since the pandemic, everybody got familiar with the key elements of pharma product development.
But let’s take a closer look into the value chain of the industry.
What does it really take to pick up a technology and bring it to patients?
Questions we will discuss:
Some questions we will focus on:
What strategic approaches do exist for life science companies?How important is the team in developing a company to an IPO?Where can scientists find help when they want to start a company?About Christoph Lengauer (from Third Rock Ventures)
“The most powerful thing about being a part of this industry is having the opportunity to improve the lives of patients and their families.”Christoph loves the ideation of new company concepts and focuses on the formation, development, and strategy of our portfolio companies. He is an accomplished scientist and drug hunter with the ability to translate that knowledge, insight, and expertise into compelling business strategies. Christoph has contributed to the discovery and development of eight FDA-approved medicines.
Christoph is dedicated to making a dramatic difference in patients’ lives. He is enthusiastic about Third Rock’s approach to discover, launch and build great companies by focusing on bold ideas that meet at the intersection of science, strategy, business, and medicine. He is especially excited by initiatives at the firm focusing on the early detection of diseases in order to not only treat but cure patients.
By leveraging his experiences and networks from academia, pharma, and biotech, he hopes to continue building great teams that help young companies succeed with this important mission.
Over his career, Christoph has received numerous awards, including the Novartis Oncology’s President’s Award for Top Innovator, and has been elected to membership in the Johns Hopkins Society of Scholars.
About Third Rock Ventures
We discover, launch, and build great companies based on bold ideas that meet at the intersection of science, strategy, business, and medicine – where transformational science meets operational reality – providing the best opportunity to make a dramatic difference in patients’ lives.
A FORMULA FOR INNOVATION
We only invest in the best of those ideas. We are actively involved in the early stages of our companies’ development, typically serving as members of the founding management teams, to build a strong foundation, put in place the right people and culture, and set the companies on a path to scientific and operational excellence. We believe in the companies we launch and make big initial investments, often complemented by strategic alliances, to enable our companies to advance life-changing therapies, devices, and diagnostics. By creating value for patients, we create value for our investors.
Link to the Video of the Recording:
YouTube

Speaker:
Christoph Lengauer
Christian Soschner
Organizations:
CS Life Science Invest
Third Rock Ventures
Support the show (https://lsg2g.substack.com/subscribe?)

1 hr 5 min